Scientific Publications Archives - Page 2 of 2 - MaaT Pharma

Posters Scientific Publications

Robust Machine Learning (ML) approach for Screening Microbiome Ecosystem Therapies (MET) Drug Candidates in combination with Immune Checkpoint Inhibitors

MaaT PharmaOctober 12, 2023

Posters Scientific Publications

Evaluation of a new co-cultured Microbiome Ecosystem Therapy candidate (MaaT03X) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors

MaaT PharmaOctober 12, 2023

Posters Scientific Publications

Benchmarking of shotgun metagenomics analysis results obtained with state-of-the-art optimized pipelines on simulated gut microbiome samples

MaaT PharmaJuly 25, 2023

Posters Scientific Publications

Restoration of gut microbiota diversity with oral pooled fecal microbiotherapy in acute myeloid leukemia patients after intensive chemotherapy: the phase 1b CIMON trial

MaaT PharmaDecember 11, 2022

Posters Scientific Publications

Pooled allogenic fecal microbiotherapy MaaT013 for the treatment of steroid-refractory gastrointestinal acute graft-versus-host disease: results from the phase IIa HERACLES study and expanded access program

MaaT PharmaNovember 13, 2022

Press Releases Scientific Publications

MaaT Pharma Announces Publication of Results from Completed Phase 1/2 ODYSSEE Clinical Trial in Nature Communications

The trial of the autologous microbial therapy, MaaT011, met its primary endpoints through demonstration of…

MaaT PharmaMay 25, 2021

Press Releases Scientific Publications

MaaT Pharma annonce la publication dans Nature Communications des résultats de l’essai clinique ODYSSEE de phase 1/2.

L'essai de la thérapie autologue de restauration du microbiote, MaaT011, a atteint ses objectifs principaux…

MaaT PharmaMay 25, 2021

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club